The researchers found that OTL38 accumulated in FRα - positive
tumors and metastases, and enabled the surgeons to remove an
additional 29 percent of malignant
lesions (confirmed by pathological examination of the resected
tumors) that could not be identified with naked eyes and / or palpation.